Characteristics | Cases (VL > 1000) (copies/µl) N = 191 | Controls (VL ≤ 1000) (copies/µl) N = 382 | P-value |
---|---|---|---|
N (%) | N (%) | ||
Gender, number (%) | |||
Male | 58 (30.4) | 116 (30.4) | – |
Female | 133 (69.6) | 266 (69.6) | – |
Age in years, median (IQR) | 37 (29−43) | 37 (29−43) | – |
18–34 | 75 (39.3) | 150 (39.3) | – |
≥ 35 | 116 (60.7) | 232 (60.7) | – |
WHO stage, number (%) | |||
1 or 2 | 73 (38.2) | 186 (48.8) | 0.02 |
3 or 4 | 118 (61.8) | 195 (51.2) | |
CD4 cell counts per µl, median (IQR) | 262 (118−429) | 500 (346−661) | < 0.01 |
Duration on ART in months, median (IQR) | 47 (27−82) | 46 (27−93) | 0.22 |
Time since HIV diagnosis in years Median (IQR) | 7 (3−11) | 8 (4−11) | 0.30 |
ART_NNRT (NVP, EFV), number (%) | 141 (74.2) | 339 (88.7) | – |
ART_PI (ATV, LPV), number (%) | 49 (25.7) | 45 (11.8) | < 0.01 |